Founded in 2018 in Yorkshire, Rinri Therapeutics may have a solution to the problem of untreated hearing loss which costs the UK economy a staggering £25.5bn a year.
The firm based at the University of Sheffield is developing the world’s first regenerative cell therapy for sensorineural hearing loss (SNHL), the most common form of deafness for which there is currently no approved pharmacological treatment.
Based on stem cell research, its treatment aims to reverse SNHL by repairing the damaged cellular structure of the inner ear. And according to the company, this technology "has the potential to address huge unmet need globally and help ease the UK’s socio-economic and healthcare burdens".
Read more at: https://www.examinerlive.co.uk/news/local-news/special-yorkshire-firm-using-stem-23134182